Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;197(6):e64003.
doi: 10.1002/ajmg.a.64003. Epub 2025 Feb 12.

Clinical Characteristics of Patients With Kabuki Syndrome at a Single Tertiary Children's Hospital

Affiliations

Clinical Characteristics of Patients With Kabuki Syndrome at a Single Tertiary Children's Hospital

Victoria Dortenzio et al. Am J Med Genet A. 2025 Jun.

Erratum in

Abstract

Kabuki syndrome (KS) is a multisystem disorder characterized by facial dysmorphic features, growth delays, skeletal anomalies, and variable intellectual disability (ID) due to pathogenic variants in KMT2D and KDM6A. Significant phenotypic variability has been reported in patients with KS. To further characterize the variability observed in the genomic sequencing era, comprehensive genotypic and phenotypic information from 36 patients with KS and likely pathogenic or pathogenic KMT2D or KDM6A variants at the Children's Hospital of Philadelphia (CHOP) was collected. Dysmorphic features, growth restriction, and developmental delays were commonly reported, as expected. Hyperinsulinism (HI) was seen more frequently than in previously published cohorts. Patients diagnosed with HI were more likely to require neonatal intensive care unit admission and feeding tube(s). Intellectual disability was variable in severity and less frequent than previously reported. This study highlights the wide phenotypic spectrum of KS and expands our knowledge of the diagnostic process for KS. This study is limited by potential ascertainment bias as CHOP is a HI Center of Excellence, however, our cohort is unique as many were ascertained with disease-agnostic testing. Screening for hyperinsulinism, including consideration of diagnostic fast, at time of KS diagnosis is warranted to prevent long-term neurologic effects of untreated hypoglycemia.

Keywords: Kabuki syndrome; development; hyperinsulinism; intellectual disability.

PubMed Disclaimer

References

    1. Adam, M. P., S. Banka, H. T. Bjornsson, et al. 2019. “Kabuki Syndrome: International Consensus Diagnostic Criteria.” Journal of Medical Genetics 56, no. 2: 89–95. https://doi.org/10.1136/jmedgenet‐2018‐105625.
    1. Adam, M. P., L. Hudgins, and M. Hannibal. 1993. “Kabuki Syndrome.” In GeneReviews ((R)), edited by M. P. Adam , J. Feldman , G. M. Mirzaa , et al., University of Washington. https://www.ncbi.nlm.nih.gov/pubmed/21882399.
    1. Banka, S., D. Lederer, V. Benoit, et al. 2015. “Novel KDM6A (UTX) Mutations and a Clinical and Molecular Review of the X‐Linked Kabuki Syndrome (KS2).” Clinical Genetics 87, no. 3: 252–258. https://doi.org/10.1111/cge.12363.
    1. Barry, K. K., M. Tsaparlis, D. Hoffman, et al. 2022. “From Genotype to Phenotype‐A Review of Kabuki Syndrome.” Genes 13, no. 10: 1761. https://doi.org/10.3390/genes13101761.
    1. Caciolo, C., P. Alfieri, G. Piccini, et al. 2018. “Neurobehavioral Features in Individuals With Kabuki Syndrome.” Molecular Genetics & Genomic Medicine 6, no. 3: 322–331. https://doi.org/10.1002/mgg3.348.

MeSH terms

Supplementary concepts